» Articles » PMID: 2428752

Antigenic and Physical Diversity of Neisseria Gonorrhoeae Lipooligosaccharides

Overview
Journal Infect Immun
Date 1986 Oct 1
PMID 2428752
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

We used mouse monoclonal antibodies (MAbs) to characterize Neisseria gonorrhoeae lipooligosaccharide (LOS). LOSs that bound two or more MAbs in a solid-phase radioimmunoassay usually bound them to different LOS components, as separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); strains with multiple LOS components on SDS-PAGE usually bound more than one MAb. However, the LOS of some strains bound the same MAb to two LOS components with different relative molecular weights, and some individual LOS components bound more than one MAb. LOSs from different strains bound different amounts of the same MAb at saturation, reflecting differences in the quantitative expression of individual LOS components. Not all components recognized by MAbs were stained by silver after periodate oxidation. Treatment with NaOH variously affected epitopes defined by different MAbs. MAb 3F11 completely inhibited and MAb 2-1-L8 partially inhibited the binding of 125I-labeled 06B4 MAb to WR220 LOS and WR220 outer membranes in competitive binding studies. Other MAbs did not compete with the binding of 125I-labeled 06B4 to either antigen. We conclude that a strain of N. gonorrhoeae elaborates multiple LOSs that can be separated by SDS-PAGE and that are antigenically distinct. Epitope expression within these glycolipids is complex.

Citing Articles

Terminal complement complexes with or without C9 potentiate antimicrobial activity against .

Lamb E, Criss A bioRxiv. 2025; .

PMID: 39868146 PMC: 11760736. DOI: 10.1101/2025.01.16.633325.


Tackling immunosuppression by Neisseria gonorrhoeae to facilitate vaccine design.

Jones R, Ramirez-Bencomo F, Whiting G, Fang M, Lavender H, Kurzyp K PLoS Pathog. 2024; 20(11):e1012688.

PMID: 39541395 PMC: 11594432. DOI: 10.1371/journal.ppat.1012688.


Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal Antibody.

Beernink P, Di Carluccio C, Marchetti R, Cerofolini L, Carillo S, Cangiano A JACS Au. 2024; 4(7):2617-2629.

PMID: 39055159 PMC: 11267536. DOI: 10.1021/jacsau.4c00359.


scavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation.

Cardenas A, Thomas K, Broden M, Ferraro N, Pires M, John C mBio. 2024; 15(5):e0011924.

PMID: 38587424 PMC: 11078009. DOI: 10.1128/mbio.00119-24.


lipooligosaccharide glycan epitopes recognized by bactericidal IgG antibodies elicited by the meningococcal group B-directed vaccine, MenB-4C.

Tzeng Y, Sannigrahi S, Borrow R, Stephens D Front Immunol. 2024; 15:1350344.

PMID: 38440731 PMC: 10909805. DOI: 10.3389/fimmu.2024.1350344.


References
1.
Rice P, Kasper D . Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. J Clin Invest. 1982; 70(1):157-67. PMC: 370238. DOI: 10.1172/jci110589. View

2.
Schneider H, Griffiss J, Mandrell R, Jarvis G . Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae. Infect Immun. 1985; 50(3):672-7. PMC: 261131. DOI: 10.1128/iai.50.3.672-677.1985. View

3.
Schneider H, Griffiss J . A bactericidal microassay for testing serum sensitivity of Neisseria gonorrhoeae. J Immunol Methods. 1982; 54(1):101-5. DOI: 10.1016/0022-1759(82)90118-1. View

4.
Zollinger W, Mandrell R . Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect Immun. 1983; 40(1):257-64. PMC: 264843. DOI: 10.1128/iai.40.1.257-264.1983. View

5.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View